Synthekine Stock

synthekine.comHealthcare / BioTech & PharmaFounded: 2018Funding to Date: $288.61MM

Synthekine is an engineered cytokine therapeutics company developing disease-optimized treatments.

Register for Details

For more details on financing and valuation for Synthekine, register or login.

Please provide a valid email address.

By registering, you agree to Forge’s Terms of Use. Already registered? Log in

OverviewFinancingsValuation

Enterprise Value (based on primary financings)

Powered by Forge Data
Enterprise Value

View Enterprise Value for Synthekine.

Register Today

Other companies like Synthekine in the BioTech & Pharma sector

Sector
Last Round Est. Valuation
$3.67B
Sector
Last Round Est. Valuation
$8.45B
Sector
Last Round Est. Valuation
$500MM
Sector
Last Round Est. Valuation
$8.84B
Sector
Last Round Est. Valuation
$1.01B
Sector
Last Round Est. Valuation
$303.94MM
Sector
Last Round Est. Valuation
$4.74B

News Highlights

Synthekine Secures $100 Million Series C Financing to Advance Pipeline of Engineered Cytokine Therapeutics | BioSpace
Synthekine Secures $100 Million Series C Financing to Advance Pipeline of Engineered Cytokine Therapeutics - read this article along with other careers information, tips and advice on BioSpace
Updated on: Sep 22, 2023